Copper-catalyzed highly switchable defluoroborylation and hydrodefluorination of 1-(trifluoromethyl)alkynes
CF 2 -containing compounds hold significant potential in drug discovery, organic synthesis, and materials science. However, synthesizing various CF 2 -containing building blocks from a single compound remains challenging. Here, we present a Cu-catalyzed, switchable defluoroborylation and hydrodefluo...
Gespeichert in:
Veröffentlicht in: | Nature communications 2024-08, Vol.15 (1), p.7079-12 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | CF
2
-containing compounds hold significant potential in drug discovery, organic synthesis, and materials science. However, synthesizing various CF
2
-containing building blocks from a single compound remains challenging. Here, we present a Cu-catalyzed, switchable defluoroborylation and hydrodefluorination of trifluoromethylated alkynes, yielding four types of CF
2
-containing compounds. The chemo- and regio-selective sp
2
/sp
3
1,2-diborylation and sp
2
monoborylation of 1-(trifluoromethyl)alkynes are controlled by adjusting the solvent and ligand quantity. Additionally, altering the base allows selective generation of
gem
-difluoroalkenes or difluoromethylalkenes. Notably, our method prevents over-defluorination of the CF
3
group on unsaturated C-C bonds during nucleophilic additions, preserving the pharmaceutically valuable CF
2
group. Experimental data and density functional theory (DFT) calculations elucidate the regioselectivities of Cu-Bpin addition and the regulatory role of the ligand in selective deborylation processes.
Achieving the modular synthesis of various CF
2
-containing building blocks from a single compound remains a formidable challenge. Herein, the authors present a Cu-catalyzed switchable defluoroborylation and hydrodefluorination of trifluoromethylated alkynes, affording four types of synthetically challenging CF
2
-containing compounds. |
---|---|
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/s41467-024-51519-y |